Gross Profit On Sales Veränderung
Alnylam Pharmaceuticals ALNY:US $ 184.01M 6.38M
Amgen AMGN:US $ 5084M 407M
AstraZeneca AZN:LN 728.3B 34.55B
Bayer BAYN:GR 7.14B 2.32B
Biogen BIIB:US $ 2105.1M 327.2M
Biomarin Pharmaceutical BMRN:US $ 410.67M 8.28M
Bristol Myers Squibb BMY:US $ 9210M 33M
ChemoCentryx CCXI:US 10.96M 5.71M
GlaxoSmithKline GSK:LN 479.3B 29.3B
Glaxosmithkline GSK:US $ 4793M 1342M
Johnson & Johnson JNJ:US $ 16101M 273M
MacroGenics MGNX:US 23.6M 12.55M
Merk MRK:US $ 10895M 328M
Novartis NOVN:VX 9.34B 277M
Pfizer PFE:US $ 19071M 3420M
Sarepta Therapeutics SRPT:US $ 195.69M 16.3M
Takeda 4502:JP Y 679583M 114674M
Teva Pharmaceutical TEVA:IT 1.83B 26M
YTE INCY:US $ 866.16M 170.14M



ChemoCentryx Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.